It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Antibodies against the Membrane-Proximal External Region (MPER) of the Env gp41 subunit neutralize HIV-1 with exceptional breadth and potency. Due to the lack of knowledge on the MPER native structure and accessibility, different and exclusive models have been proposed for the molecular mechanism of MPER recognition by broadly neutralizing antibodies. Here, accessibility of antibodies to the native Env MPER on single virions has been addressed through STED microscopy. STED imaging of fluorescently labeled Fabs reveals a common pattern of native Env recognition for HIV-1 antibodies targeting MPER or the surface subunit gp120. In the case of anti-MPER antibodies, the process evolves with extra contribution of interactions with the viral lipid membrane to binding specificity. Our data provide biophysical insights into the recognition of the potent and broadly neutralizing MPER epitope on HIV virions, and as such is of importance for the design of therapeutic interventions.
The Membrane-Proximal External Region (MPER) of the HIV Env gp41 subunit is a target for broadly neutralizing antibodies. Here, the authors apply super-resolution stimulated emission depletion (STED) microscopy on single virions and provide insights into how the MPER epitope is recognized.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Chojnacki Jakub 2
; Rujas Edurne 1 ; Insausti, Sara 1 ; Largo Eneko 1 ; Waithe Dominic 2
; Apellaniz Beatriz 1 ; Sicard Taylor 3 ; Jean-Philippe, Julien 4
; Eggeling, Christian 5 ; Nieva, José L 1 1 University of the Basque Country (UPV/EHU), Biofisika Institute (CSIC, UPV/EHU) and Department of Biochemistry and Molecular Biology, Bilbao, Spain (GRID:grid.11480.3c) (ISNI:0000000121671098)
2 University of Oxford, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
3 The Hospital for Sick Children Research Institute, Program in Molecular Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) ; University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
4 The Hospital for Sick Children Research Institute, Program in Molecular Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) ; University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) ; University of Toronto, Department of Immunology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
5 University of Oxford, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) ; Institute of Applied Optics Friedrich-Schiller-University Jena, Jena, Germany (GRID:grid.9613.d) (ISNI:0000 0001 1939 2794) ; Leibniz Institute of Photonic Technology e.V., Jena, Germany (GRID:grid.418907.3) (ISNI:0000 0004 0563 7158)




